Valeant Isn’t Out Of The Woods Yet

Investors initially celebrated a mixed Q2 earnings report from Valeant Pharmaceuticals Intl Inc VRX 0.46% to the tune of a 7 percent Tuesday-morning pop for the stock. However, that enthusiasm quickly evaporated as the reality of yet another guidance cut and an uncertain future started to sink in.

What A Difference 24 Hours Makes For Valeant

Valeant Pharmaceuticals Intl Inc VRX 0.46% shares initially jumpedmore than 7 percent following the company’s second-quarter earnings report. However, in a matter of 24 hours, that gain is completely gone and the stock is trading significantly lower than it was prior to the report.

Bitcoin Investors Just Received A Big Breakthrough

On Wednesday, cryptocurrencies like bitcoin and Ethereum took a major step in becoming mainstream investment options. Fidelity Investments announced that its clients will now be able to integrate their cryptocurrency investments held on Coinbase’s digital wallet platform into their Fidelity accounts.

Bitcoin Investors Just Received A Big Breakthrough

On Wednesday, cryptocurrencies like bitcoin and Ethereum took a major step in becoming mainstream investment options. Fidelity Investments announced that its clients will now be able to integrate their cryptocurrency investments held on Coinbase’s digital wallet platform into their Fidelity accounts.